Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/10/2010US7771757 For topical application and saturation of portions of sinus physiology, comprising water, zinc acetate, alkaloids; plant extract of grapefruit seed; for therapy of cold or flu
08/10/2010US7771756 administering the nutraceuticals comprising flavonoids from plant extracts, carotenoids, and a neurotransmitter amino acid; particularly for children
08/10/2010US7771750 A pelletized composition comprising a core which comprises an inert carrier, having at least one aminoketone antidepressant layered thereon,specifically, a core of bupropion hydrochloride and bupropion hydrochloride; 24-hour efficacy with once daily dosing, with less than 50% of the drug released at 10
08/10/2010US7771749 Aqueous emulsion
08/10/2010US7771748 Reducing smoking; side effect reduction
08/10/2010US7771747 Gastric acid secretion inhibiting composition
08/10/2010US7771746 Combining alpha -dihydroergocryptine with a p hydrophilic swelling agent of hydroxyalkylcelluloses, polyvinyl alcohols, polyoxyethylene glycols, carbomers, poloxamers and excipients; improving bioavailability
08/10/2010US7771744 Bazedoxifene acetate formulations
08/10/2010US7771742 Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
08/10/2010US7771739 Implantable medical devices comprising semi-crystalline poly(ester-amide)
08/10/2010US7771737 Medium chain peroxycarboxylic acid compositions
08/10/2010US7771736 Glyphosate formulations and their use for the inhibition of 5-enolpyruvylshikimate-3-phosphate synthase
08/10/2010US7771733 Compositions and methods for enhancing corticosteroid delivery
08/10/2010US7771726 Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases
08/10/2010US7771723 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
08/10/2010US7771721 Methods for using chimeric vascular endothelial growth factor receptor proteins
08/10/2010US7771712 lactic acid, caproic acid, and ammonia
08/10/2010US7771711 Sphingolipids' polyalkylamines conjugates
08/10/2010US7771707 Abuse-deterrent drug formulations
08/10/2010US7771413 Fluid medication delivery device
08/10/2010US7770577 Methods and devices for treating lung dysfunction
08/10/2010CA2606719C Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for producing the same
08/10/2010CA2559397C Substituted morpholine and thiomorpholine derivatives
08/10/2010CA2547334C Methods and compositions for deterring abuse of opioid containing dosage forms
08/10/2010CA2535646C Cyclopropyl derivatives as nk3 receptor antagonists
08/10/2010CA2530583C The polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid
08/10/2010CA2528818C Topical aerosol foams
08/10/2010CA2527375C Beta-strand mimetics and methods relating thereto
08/10/2010CA2527315C Imidazole derivatives as glutamate receptor antagonists
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2487252C Esters in position 20 of camptothecins
08/10/2010CA2483159C Triazole derivatives as tachykinin receptor antagonists
08/10/2010CA2477967C Purine derivatives as kinase inhibitors
08/10/2010CA2476490C Indole derivatives substituted with long-chain alcohols and medicaments containing them
08/10/2010CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
08/10/2010CA2471745C 25-hydroxy vitamin d3 compositions
08/10/2010CA2471147C Nitric oxide donors for treatment of disease and injury
08/10/2010CA2467013C Substituted benzopyrans as selective estrogen receptor-beta agonists
08/10/2010CA2463227C Steroidal compounds for inhibiting steroid sulphotase
08/10/2010CA2462694C Neurotensin active 2,3-diaryl-pyrazolidine derivatives
08/10/2010CA2462132C 1,2,4-triazole compounds
08/10/2010CA2451605C Diamine derivatives
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2450313C Process for the production of the piperidine derivative fexofenadine
08/10/2010CA2447021C Pyridyl cyanoguanidine compounds
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/10/2010CA2419801C Steroid derived antibiotics
08/10/2010CA2415957C Dry powder formulation comprising racecadotril
08/10/2010CA2413809C Synergistic antiplaque/antigingivitis oral composition
08/10/2010CA2395980C 10, 11-difluoromethylenedioxycamptothecin compounds with topoisomerase i inhibition
08/10/2010CA2391832C Oral dosage forms
08/10/2010CA2389647C Isoxazole derivatives as phosphodiesterase vii inhibitors
08/10/2010CA2383493C Treating prostate cancer with anti-erbb2 antibodies
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2362864C New gymnemic acid derivatives, their preparation, pharmaceutical composition containing them and their medical use
08/10/2010CA2250309C Steroids as neurochemical initiators of change in human blood levels of lh or fsh
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/10/2010CA2243235C Immunotherapy using cytotoxic t lymphocytes (ctl)
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/10/2010CA2235627C Receptor and nucleic acid molecule encoding said receptor
08/10/2010CA2215827C O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
08/10/2010CA2191302C Pharmaceutical preparation with a hydrophobic active substance and an effervescent system, and process for preparing said preparation
08/10/2010CA2180032C Gene expression control
08/05/2010WO2010088700A1 Methods for improving cognitive function and decreasing heart rate
08/05/2010WO2010088574A1 Azabenzimidazoles and related analogs as sirtuin modulators
08/05/2010WO2010088564A2 Compositions and methods for the treatment of cancer
08/05/2010WO2010088544A1 Methods to treat cancer
08/05/2010WO2010088498A1 Methods for treating estrogen receptor positive cancer by x-box binding protein 1 inhibition
08/05/2010WO2010088455A2 Cromolyn derivatives and related methods of imaging and treatment
08/05/2010WO2010088450A2 Methods for treating diseases associated with the modulation of serca
08/05/2010WO2010088414A2 Subunit selective nmda receptor potentiators for the treatment of neurological conditions
08/05/2010WO2010088400A1 Methods of diagnosing and treating neurodegenerative diseases
08/05/2010WO2010088394A1 Compounds
08/05/2010WO2010088392A1 Carboxamide compounds and methods for using the same
08/05/2010WO2010088385A1 Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrol o [3,4-b] pyrazine and methods for measuring effectiveness of coating
08/05/2010WO2010088375A2 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
08/05/2010WO2010088368A2 Imidazopyrazines as protein kinase inhibitors
08/05/2010WO2010088336A1 Solid oral formulations of a pyridopyrimidinone
08/05/2010WO2010088335A1 Substituted benzimidazoles for the treatment of astrocytomas
08/05/2010WO2010088331A1 Crystalline n-{(1-s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
08/05/2010WO2010088304A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010WO2010088225A2 Regulation of mammalian keratinous tissue using skin and/or hair care actives
08/05/2010WO2010088222A2 A high molecular weight polysaccharide that binds and inhibits virus
08/05/2010WO2010088212A1 Long wear lip product
08/05/2010WO2010088203A1 Therapeutic treatment of cancer and dysplasia of the cervix or vagina using estrogen antagonists
08/05/2010WO2010088195A1 Azaquinazolinediones useful as chymase inhibitors
08/05/2010WO2010088191A1 Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
08/05/2010WO2010088167A1 Bridged compounds as hiv integrase inhibitors
08/05/2010WO2010088071A1 Use of whole grain materials with high resistant starch for satiety, reduction of food intake and weight management
08/05/2010WO2010088064A2 Preservation of ergothioneine
08/05/2010WO2010088050A2 Bicyclic pyrazolo-heterocycles
08/05/2010WO2010088000A2 Antifibrotic compounds and uses thereof
08/05/2010WO2010087982A1 Glur2 receptor modulators
08/05/2010WO2010087947A2 Transdermal delivery of diclofenac, carbamazepine and benzydamine
08/05/2010WO2010087781A1 Polyelectrolyte complexes with bound peptides
08/05/2010WO2010087770A1 Novel process for preparing carboxy-containing pyrazoleamido compounds 597
08/05/2010WO2010087762A1 2-aza-bicyclo[2.2.1]heptane compounds and uses thereof
08/05/2010WO2010087761A1 2-aza-bicyclo[2.2.2]octane compounds and uses thereof
08/05/2010WO2010087693A1 Composition comprising oil palm phenolics for use in providing neuroprotective effects and cognitive-enhancement
08/05/2010WO2010087594A9 Cd93 or use of soluble fragment thereof
1 ... 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 ... 7860